| Literature DB >> 35822793 |
Wirot Likittrakulwong1, Pisit Poolprasert2, Worawatt Hanthongkul3, Sittiruk Roytrakul4.
Abstract
This research aimed to investigate the effects of the intramuscular injection of vitamins AD3E and C in combination immediately before the estrus synchronization program (the Ovsynch program) on conception and pregnancy rates, blood parameters, serum biochemical properties, immune systems, antioxidant parameters, and proteomic and transcriptomic analyses during early gestation in dairy cows. Forty nonlactating multiparous cows were randomly assigned to one of four treatments: (1) C: control with normal saline injection; (2) VAD3E: a single intramuscular injection (I/M) of vitamin AD3E; (3) VAD3EC: injection of both vitamins AD3E and C; (4) VC: a single dose of vitamin C. Blood and serum samples were taken immediately at day 0 (before AI), day 7, and day 14 (after AI for 5 days) from the coccygeal vein. Generally, injections of AD3E and C in combination had no effect on the rate of conception or pregnancy. However, they improved hematological parameters and immune and antioxidant activities. Serum samples were analyzed using LC-MS/MS, and 8190 proteins were identified. Five proteins were successfully validated using the quantitative real-time reverse transcription PCR (qRT-PCR) method. This study found that lymphocyte-specific protein 1 (LSP1, A0A3Q1M894) could be used as a protein biomarker for cows administrated with vitamins AD3E and C.Entities:
Keywords: LC-MS/MS; Ovsynch program; dairy cows; gene expression; protein expression profiles; vitamin C; vitamins AD3E
Year: 2022 PMID: 35822793 PMCID: PMC9264402 DOI: 10.3390/biotech11020020
Source DB: PubMed Journal: BioTech (Basel) ISSN: 2673-6284
Figure 1Diagram showing estrous synchronization plus timed AI protocol. (1, C): the control treatment for which cows were injected with normal saline; (2, VAD3E): cows injected with vitamin AD3E; (3, VAD3EC): cows received both vitamins AD3E and C; (4, VC): cows injected with vitamin C; CIDR–B: progesterone release device; GnRH: gonadotropin–releasing hormone analogue; PGF2α: prostaglandin F2 alpha; AI: artificial insemination.
Specific primers used in the experiments.
| Gene 1 | Sequence (5′-3′) | Accession No. | Ref. |
|---|---|---|---|
| IL-10 | F: TTCTGCCCTGCGAAAACAA | NM_174088 | [ |
| R: TCTCTTGGAGCTCACTGAAGACTCT | |||
| TNFα | F: TGACGGGCTTTACCTCATCT | AF_348421 | [ |
| R: TGATGGCAGACAGGATGTTG | |||
| ISG15 | F: GGTATCCGAGCTGAAGCAGTT | NM_174366 | [ |
| R: ACCTCCCTGCTGTCAAGGT | |||
| SOD1 | F: TGTTGCCATCGTGGATATTGTAG | NM_174615 | [ |
| R: CCCAAGTCATCTGGTTTTTCATG | |||
| CAT | F: GCTCCAAATTACTACCCCAATAGC | NM_001035386 | [ |
| R: GCACTGTTGAAGCGCTGTACA | |||
| Beta-actin | F: GCGTGGCTACAGCTTCACC | AY141970 | [ |
| R: TTGATGTCACGGACGATTTC |
1 IL-10: interleukin-10; TNFα: tumor necrosis factor alpha; ISG15: interferon-stimulated gene 15; SOD1: superoxide dismutase1; CAT: catalase. Ref: reference.
Effects of various vitamins on estrus detection, conception rate, and pregnancy rate in dairy cows over 60 days.
| Items | C | VAD3E | VAD3EC | VC | |
|---|---|---|---|---|---|
| Estrus detection AI% | 100.0 | 90.00 | 100.00 | 100.00 | 0.380 |
| Detections/all cows | 10/10 | 9/10 | 10/10 | 10/10 | |
| Conception Rate AI% | 10.0 | 30.0 | 20.0 | 40.0 | 0.446 |
| Detections/all cows | 1/10 | 3/10 | 2/10 | 4/10 | |
| Pregnancy Rate% | 10.0 | 30.0 | 20.0 | 40.0 | 0.446 |
| Detections/all cows | 1/10 | 3/10 | 2/10 | 4/10 |
C: the control treatment for which cows were injected with normal saline; VAD3E: cows were injected with vitamin AD3E; VAD3EC: cows received both vitamins AD3E and C; VC: cows were injected with vitamin C; AI: artificial insemination; conception detected by aggression check via the anus during the 45-day (conception rate) and 60-day (pregnancy rate) periods after artificial insemination.
Effect of various vitamin on hematology parameters in dairy cows for 14 days.
| Items | C | VAD3E | VAD3EC | VC | |
|---|---|---|---|---|---|
| RBC (×106 cells/mm3) | 6.44 ± 0.34 | 4.96 ± 0.55 | 5.78 ± 0.49 | 5.22 ± 0.40 | 0.138 |
| Ht (%) | 30.20 ± 1.53 | 23.20 ± 2.76 | 28.40 ± 3.37 | 24.40 ± 2.99 | 0.270 |
| Hgb (g/dL) | 9.52 ± 0.41 | 7.46 ± 0.81 | 8.48 ± 0.88 | 7.94 ± 0.87 | 0.299 |
| MCV (fL) | 43.38 ± 1.27 | 47.92 ± 2.85 | 49.04 ± 1.82 | 46.82 ± 2.68 | 0.910 |
| MCHC (g/dL) | 31.28 ± 0.33 | 31.26 ± 0.33 | 28.74 ± 0.87 | 32.20 ± 1.48 | 0.075 |
| WBC (cells/mm3) | 16,640 ± 7124.79 b | 16,620 ± 5956.37 b | 46,580 ± 7362.50 a | 8460 ± 1148.74 b | 0.002 |
| Neu (%) | 51.80 ± 12.46 a | 24.80 ± 8.35 b | 14.80 ± 3.11 b | 19.40 ± 4.83 b | 0.015 |
| Eos (%) | 2.80 ± 0.86 | 1.40 ± 0.24 | 1.40 ± 0.40 | 2.00 ± 0.55 | 0.280 |
| Lin (%) | 43.80 ± 13.07 b | 72.40 ± 8.29 a | 81.40 ± 1.40 a | 77.40 ± 2.23 a | 0.015 |
| Mon (%) | 1.80 ± 0.20 | 1.80 ± 0.37 | 2.20 ± 0.49 | 1.60 ± 0.40 | 0.730 |
| PLT (cells/mm3) | 201,600 ± 29,512.03 b | 208,400 ± | 231,200 ± 35,319.12 b | 376,400 ± 36,912.87 a | 0.002 |
C: the control treatment for which cows were injected with normal saline; VAD3E: cows injected with vitamin AD3E; VAD3EC: cows received both vitamins AD3E and C; VC: cows were injected with vitamin C; RBC: red blood cells; Hb: hemoglobin; Ht: hematocrit; Hgb: hemoglobin; MCV: mean corpuscular volume; MCHC: mean corpuscular hemoglobin concentration; WBC: white blood cells; Neu: neutrophils; Eos: eosinophils; Lin: lymphocytes; Mon: monocytes; PLT: platelet cells. a,b Means with different superscripts in a column differ significantly (p < 0.05).
Effects of various vitamins on biochemical parameters of serum in dairy cows over 14 days.
| Items | C | VAD3E | VAD3EC | VC | |
|---|---|---|---|---|---|
| BUN, mg/dL | 4.60 ± 0.51 c | 28.60 ± 1.12 a | 15.00 ± 1.52 b | 8.00 ± 2.07 c | ≤0.01 |
| GLU, mg/dL | 4.50 ± 0.22 | 4.60 ± 1.29 | 2.00 ± 0.32 | 2.96 ± 0.50 | 0.057 |
| ALB, g/dL | 2.48 ± 0.12 b | 3.14 ± 0.18 a | 3.32 ± 0.17 a | 3.16 ± 0.06 a | 0.003 |
| TG, mg/dL | 8.20 ± 0.20 | 9.20 ± 0.37 | 10.60 ± 1.36 | 8.40 ± 1.25 | 0.303 |
| CHO, mg/dL | 82.40 ± 2.98 c | 168.40 ± 3.97 a | 122.60 ± 8.73 b | 126.40 ± 7.34 b | ≤0.01 |
| Ca, mg/dL | 8.36 ± 0.27 | 8.36 ± 0.42 | 8.56 ± 0.25 | 9.24 ± 0.09 | 0.132 |
| P, mg/dL | 9.54 ± 0.74 | 8.30 ± 0.18 | 9.40 ± 0.33 | 8.94 ± 0.88 | 0.486 |
| P4, ng/mL | 0.80 ± 0.25 | 0.82 ± 0.34 | 1.02 ± 0.10 | 1.09 ± 0.39 | 0.856 |
| E, pg/mL | 21.20 ± 10.80 | 11.60 ± 1.03 | 40.16 ± 16.83 | 11.60 ± 1.03 | 0.168 |
| Cortisol, µg/dL | 1.19 ± 0.46 | 0.43 ± 0.24 | 0.71 ± 0.55 | 0.33 ± 0.18 | 0.190 |
C: the control treatment for which cows were injected with normal saline; VAD3E: cows were injected with vitamin AD3E; VAD3EC: cows received both vitamins AD3E and C; VC: cows were injected with vitamin C; BUN: blood urea nitrogen; GLU: glucose, ALB: albumin; TG: triglyceride; CHO: cholesterol; Ca: calcium; P: phosphorus; P4: progesterone; E: estrogen. a–c Means with different superscripts in a column differ significantly (p ≤ 0.05).
Effects of various vitamins on immune and antioxidant activity levels in serum samples from dairy cows over 14 days.
| Items | C | VAD3E | VAD3EC | VC | |
|---|---|---|---|---|---|
| ACH50, U/mL | 294.11 ± 6.24 c | 394.95 ± 20.04 a | 365.05 ± 22.94 ab | 342.14 ± 10.04 bc | 0.004 |
| Total Ig, mg/mL | 1.34 ± 0.12 b | 2.61 ± 0.13 a | 2.53 ± 0.20 a | 2.59 ± 0.14 a | ≤0.01 |
| LZY, U/mL | 335.10 ± 13.26 b | 499.00 ± 33.60 a | 478.83 ± 30.80 a | 328.53 ± 24.05 b | <0.01 |
| SOD, | 85.22 ± 0.73 c | 89.26 ± 1.72 b | 94.48 ± 0.72 a | 91.42 ± 0.49 ab | ≤0.01 |
| CAT, mU/mL | 0.20 ± 0.00 b | 0.01 ± 0.00 d | 0.23 ± 0.01 a | 0.07 ± 0.01 c | ≤0.01 |
| GPx, mU/mL | 0.09 ± 0.01 c | 0.09 ± 0.00 bc | 0.10 ± 0.00 ab | 0.11 ± 0.01 a | 0.003 |
| GR, U/mL | 0.16 ± 0.01 c | 0.23 ± 0.02 a | 0.26 ± 0.01 a | 0.20 ± 0.01 b | ≤0.01 |
C: the control treatment for which cows were not injected with any vitamins; VAD3E: cows were injected with vitamin AD3E; VAD3EC: cows received both vitamins AD3E and C; VC: cows were injected with vitamin C; ACH50: alternative complement hemolytic 50; Total Ig: total immunoglobulin; LZY: lysozyme activities; SOD: superoxide dismutase activities; CAT: catalase activities; GPx: glutathione peroxidase activities; GR: glutathione reductase activities. a–d Means with different superscripts in a column differ significantly (p ≤ 0.05).
Figure 2Functional classification of biological processes of serum protein samples from dairy cows during a 14 day period.
Figure 3Overlap of identified and abundance proteins in all treatments. C: the control treatment for which cows were injected with normal saline; VAD3E: cows injected with vitamin AD3E; VAD3EC: cows received both vitamins AD3E and C; VC: cows injected with vitamin C; C, green; VAD3E, blue; VAD3EC, pink; VC, yellow.
The list of differentially abundant proteins in all treatments during different times.
| Log2 Abundance of Protein 1 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Day 0 | Day 7 | Day 14 | |||||||||||||||
| Uniprot Accession Number | Protein Name | Unique Peptide Sequence | ID Scores | MH+(Da) | C | VAD3E | VAD3EC | VC | C | VAD3E | VAD3EC | VC | C | VAD3E | VAD3EC | VC | |
| 1. | A0A3Q1M894 | Lymphocyte-specific protein 1 | LEQYTQAVEIAGR | 7.23 | 1477.08 | 0 | 0 | 0 | 0 | 0 | 0 | 17.51 | 0 | 0 | 17.43 | 0 | 0 |
| 2. | A0A3Q1MVU8 | Cytokine synthesis inhibitory factor (interleukin-10) | CHRFLPCENK | 9.90 | 1359.95 | 15.81 | 15.43 | 15.79 | 14.74 | 16.20 | 14.08 | 14.90 | 15.30 | 14.78 | 17.09 | 14.97 | 13.20 |
| 3. | E1BLB2 | TNF-alpha-induced protein 1 | DVIGDEICCWSFYGQGRK | 2.61 | 2190.44 | 15.67 | 14.40 | 16.02 | 17.99 | 15.37 | 14.21 | 13.39 | 14.81 | 14.55 | 14.76 | 13.90 | 14.52 |
| 4. | F6Q4D3 | ISG15 protein conjugation | KAEVAAEATR | 14.75 | 1045.19 | 16.60 | 15.79 | 16.06 | 15.29 | 16.18 | 15.48 | 15.16 | 16.57 | 16.87 | 16.58 | 15.34 | 15.71 |
| 5. | E1BHL1 | Superoxide dismutase (Mn), mitochondrial (EC 1.15.1.1) | AGGGAAAVVSLR | 5.20 | 1029.35 | 16.47 | 16.50 | 16.36 | 16.41 | 16.59 | 16.24 | 16.28 | 16.30 | 15.41 | 16.05 | 15.54 | 16.04 |
| 6. | A0A3Q1LKF1 | Catalase (EC 1.11.1.6) | GIPDGHRHMNGYGSHTFK | 12.03 | 2009.90 | 14.91 | 16.18 | 15.46 | 16.14 | 15.120 | 13.40 | 15.39 | 14.87 | 15.57 | 20.47 | 14.83 | 15.68 |
1 The levels of proteins in each sample are presented as log2 values; C: the control treatment for which cows were injected with normal saline; VAD3E: cows were injected with vitamin AD3E; VAD3EC: cows received both vitamins AD3E and C; day 0: early interval time; day 7: middle interval time; day 14: late interval time.
Figure 4The mRNA expression levels in blood samples of dairy cows over 14 days with different treatments. (a–e) The mRNA expression levels of IL-10, INF-α, ISG15, SOD1, and CAT in dairy cows with different treatments. Data are presented as means ± SE. Different lowercase letters above each bar indicate significant differences at the same time point (p < 0.05). White filled bar: C; light gray filled bar: VAD3E; gray filled bar: VAD3EC; black filled bar: VC. C: the control treatment for which cows were injected with normal saline; VAD3E: cows injected with vitamin AD3E; VAD3EC: cows received both vitamins AD3E and C; VC: cows injected with vitamin C; Day 0: at 0 days (early interval time); Day 7: at 7 days (middle interval time); Day 14: at 14 days (late interval time).
Figure 5The network of the one identified protein of interest and five interacting proteins predicted by STITCH database based on the following analysis parameters: species (Bos tarus); medium confidence score (0.4); active prediction method (no more than 10 interactions). The one protein of interest is lymphocyte-specific protein 1 (LSP1); the five interacting proteins include (1) interleukin 10 (IL-10), (2) tumor necrosis factor-alpha (TNF-α), (3) interferon-stimulated gene 15 (ISG15), (4) superoxide dismutase 1 (Cu-Zn) (SOD1), and (5) catalase (CAT), as well as the inducing agent (vitamin A, vitamin D, vitamin E, and ascorbate). Abbreviation: Glutathione dimer formed by a disulfide bone (GSSG), glutathione reductase (GSR), glutathione S-tranferase P (GSTP1), glutathione peroxidase 2 (GPX2), glutathione peroxidase (ENSBTAG00000046926), superoxide dimutase 2 (Mn) (SOD2), hydrogen peroxide (Hydrogen perox), vitamin D25–hydorxylase (CYP2R1), cellular tumor antigen p53 (TP53), interleukin-10 receptor subunit alpha precursor (IL10RA), ubiquitin-like modifier-activating enzyme 7 (UBA7), catenin beta-1 (CTNNB1), interferon regulatory factor 3 (IRF3), CREB-binding protein (CREBBP), uncharacterized protein (NCOA3), uncharacterized protein (CARM1), tumor necrosis factor receptor type 1-associated DEATH domain protein (TRADD), tumor necrosis factor receptor superfamily (TNFRSF1A), cyclic AMP-responsive element-binding protein 1 (CREB1), heat shock protein beta 1 (HSPB1), MAP kinase-activated protein kinase 3 (MAPKAPK3), MAP kinase-activated protein kinase2 (MAPKAPK2).